SNDX vs UNP · rev $137.7M vs P/E 21, rev $6.86B
Syndax Pharmaceuticals Inc (SNDX) versus Union Pacific Corporation (UNP) — a side-by-side from cached financials, not a winner call.
Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.
Union Pacific Corporation (UNP) is a railroads company listed on NYSE.
Latest reported SNDX revenue for 2026-06-30 was $137.7M. Net income was -$92.0M. SNDX currently screens at market cap $774.4M.
Latest reported UNP revenue for 2026-06-30 was $6.86B. Net income was $1.99B. Revenue was up 10.4% from 2026-03-31 to 2026-06-30. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
SNDX currently screens at market cap $774.4M. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
Not investment advice. Open the SNDX and UNP stock pages for the full models.
Not investment advice.